secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2022-10-12T23:59:59+00:00
Accession:  0001906324-22-000026
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho reports preliminary Q3 2022 revenue $782-785M; COVID revenue ~$171M
-------------------------------------------------------------------------------

- Total revenue expected $782M-$785M; non-COVID product revenue $611M-$614M.
- COVID-19 product revenue ~$171M, including unanticipated government order and strong retail demand.
- Strong performance in Transfusion Medicine and Sofia platform; Labs challenged by China and supply chain.
- Full Q3 2022 financial results to be reported on November 2, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632422000026/0001906324-22-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632422000026/qdel-20221012.htm
  HTML page:      https://secwatch.observer/filing/0001906324-22-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer